Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
- 12 June 2003
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (13) , 7785-7790
- https://doi.org/10.1073/pnas.1432908100
Abstract
Vascular endothelial growth factor (VEGF) is a critical promoter of blood vessel growth during embryonic development and tumorigenesis. To date, studies of VEGF antagonists have primarily focused on halting progression in models of minimal residual cancer. Consistent with this focus, recent clinical trials suggest that blockade of VEGF may impede cancer progression, presumably by preventing neoangiogenesis. However, VEGF is also a key mediator of endothelial-vascular mural cell interactions, a role that may contribute to the integrity of mature vessels in advanced tumors. Here, we report that high-affinity blockade of VEGF, using the recently described VEGF-Trap, abolishes mature, preexisting vasculature in established xenografts. Eradication of vasculature is followed by marked tumor regression, including regression of lung micrometastases. Thus, the contribution of relatively low levels of VEGF to vessel integrity may be critical to maintenance of even very small tumor masses. Potent blockade of VEGF may provide a new therapeutic option for patients with bulky, metastatic cancers.Keywords
This publication has 20 references indexed in Scilit:
- Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastomaProceedings of the National Academy of Sciences, 2002
- Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in TumorsPublished by Elsevier ,2002
- Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transferProceedings of the National Academy of Sciences, 2001
- Quantitative Assessment of Angiogenesis and Tumor Vessel Architecture by Computer-Assisted Digital Image Analysis: Effects of VEGF–Toxin Conjugate on Tumor Microvessel DensityMicrovascular Research, 2000
- Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumorJournal of Pediatric Surgery, 2000
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Anti-AngiogenesisAnnals of Surgery, 1972